Razionale scientifico

The aim of the 2026 Edition of "Respiration Day" is to provide the view of where the Respiratory clinicians and researchers are and where they are heading in the field of chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis and their comorbidities, and the role of small airway diseases in these respiratory diseases. The invited members of the Faculty are among the most productive international clinical scientists in the field chronic airway diseases, the audience will be 350 national top national clinical opinion leaders selected from more than 20 countries. The main aim of the meeting is educational, and the speakers have been specifically invited to translate in their lectures the most important recent discoveries to the potential improvement of clinical practice. A significant proportion of time (40%) will be devoted to discussion. The Meeting is divided in 5 sessions. The first session will focus on the recent advancements in COPD and its comorbidities, and in particular the first lecture will focus on the need to better characterize the different phenotypes included under the umbrella of the term COPD, both in term of etiology and clinical presentation, early diagnosis, and active search of multimorbidity to improve the management of individual patients. The second lecture will be devoted to novel therapies for COPD, particularly the biologics, with the aim of improved comprehensive and personalized management. The third lecture will focus on the major cardiovascular risk in patients with COPD, both in stable and during and in the aftermath of exacerbations of respiratory symptoms. The second session will focus on asthma as a disease of both central and peripheral airways, the need of integration of traditional pharmacological inhalation treatments with systemic agents and/or biologics, the third the ongoing research focused on mechanisms rather than clinical treatable traits. The third session will be devoted to the importance and impact of small airways dysfunction for chronic airway diseases, and in particular on the fundamental role of inhalers but also of their environmental impact, its complex impact on respiratory and non-respiratory components of chronic airway diseases, and last, but not least, how can AI help us to understand the role of small airways dysfunction. The fourth session will be devoted to the novel discoveries in the field of pathology of chronic airway diseases, and particularly the importance of mucus plugs, and mucociliary clearance. Finally the fifth session will be devoted to bronchiectasis that in the last 15 years has been discovered to represent not only a treatable trait of other chronic airway diseases but also an independent treatable disease.

Luogo

Starhotels Du Parc
Via Piacenza 12/c, Parma (PR)

Programma

Responsabili del corso

• Dario Olivieri

  Responsabile scientifico

  Specializzazione: Docente Presso L'Universita' di Parma

  Struttura: Università di Parma

  Ruolo: Professor of Respiratory Disease

Relatori e docenti

• Alvar Agusti

  Relatore

  Specializzazione: Respiratory Medicine

  Struttura: University of Barcelona and Hospital Clinic, Barcelona, Spain

  Ruolo: Professor of Medicine at the University of Barcelona and senior consultant at Hospital Clinic

• Stefano Aliberti

  Relatore

  Specializzazione: Malattie dell'Apparato Respiratorio

  Struttura: Humanitas University, Milan, Italy

  Ruolo: Direttore del Programma di Fellowship in Malattie dell'Apparato Respiratorio, Dipartimento di Scienze Biomediche

• Surya Bhatt

  Relatore

  Specializzazione: Internal Medicine

  Struttura: University of Alabama, Birmingham, UK

  Ruolo: Professor of Medicine - Pulmonary, Allergy, & Critical Care Medicine

• Matteo Bonini

  Relatore

• Guy Brusselle

  Relatore

Con il contributo non vincolante di

Domande frequenti